2013•Unpublished venueRequires access
Special Applications of Pharmacoepidemiology
The following individuals contributed to writing sections of this chapter:, David Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Claudia Vellozzi, Robert T. Chen, Jason M. Glanz, Danica Marinac‐Dabic, Sharon‐Lise T. Normand, Art Sedrakyan, Allen A. Mitchell, Gerald J. Dal Pan, Stella Blackburn, Claudia Manzo, Hanna M. Seidling, David W. Bates, Melissa A. Robb, Rachel E. Sherman, Brian L. Strom, Rita Schinnar, Sean Hennessy
Open publisher page 8 citations
Abstract
This chapter presents selected special applications of pharmacoepidemiology, which include studies of drug utilization; evaluating and improving physician prescribing; special methodological issues in pharmacoepidemiology of vaccine safety; and pharmacoepidemiologic studies of devices. Studies of drug-induced birth defects; pharmacoepidemiology and risk management; the use of pharmacoepidemiology to study medication errors; Food and Drug Administration (FDA) Sentinel Initiative; and comparative effectiveness research are the other studies. The chapter also presents this information using a standard format, focusing on clinical and methodological problems, examples of solutions, and perspectives on the future. Each application section then ends with a case example and key points.